AIMS/HYPOTHESIS: Cytokine-induced beta cell toxicity is abrogated by non-selective inhibitors of lysine deacetylases (KDACs). The KDAC family consists of 11 members, namely histone deacetylases HDAC1 to HDAC11, but it is not known which KDAC members play a role in cytokine-mediated beta cell death. The aim of the present study was to examine the KDAC gene expression profile of the beta cell and to investigate whether KDAC expression is regulated by cytokines. In addition, the protective effect of the non-selective KDAC inhibitor ITF2357 and interdependent regulation of four selected KDACs were investigated. METHODS: The beta cell line INS-1 and intact rat and human islets were exposed to cytokines with or without ITF2357. Expression of mRNA was assessed by real-time PCR and selected targets validated at the protein level by immunoblotting. Effects on cytokine-induced toxicity were investigated by in vitro assays. RESULTS: Hdac1 to Hdac11 were expressed and differentially regulated by cytokines in INS-1 cells and rat islets. HDAC1, -2, -6 and -11 were found to be expressed and regulated by cytokines in human islets. ITF2357 protected against cytokine-induced beta cell apoptosis and counteracted cytokine-induced attenuation of basal insulin secretion. In addition, cytokine-induced regulation of Hdac2 and Hdac6, but not Hdac1 and Hdac11, was reduced by KDAC inhibition. CONCLUSIONS/ INTERPRETATION: All classical KDAC genes are expressed by beta cells and differentially regulated by cytokines. Based on the relative expression levels and degree of regulation by cytokines, we propose that HDAC1, -2, -6 and -11 are of particular importance for beta cell function. These observations may help in the design of specific KDAC inhibitors to prevent beta cell destruction in situ and in islet grafts.
AIMS/HYPOTHESIS: Cytokine-induced beta cell toxicity is abrogated by non-selective inhibitors of lysine deacetylases (KDACs). The KDAC family consists of 11 members, namely histone deacetylases HDAC1 to HDAC11, but it is not known which KDAC members play a role in cytokine-mediated beta cell death. The aim of the present study was to examine the KDAC gene expression profile of the beta cell and to investigate whether KDAC expression is regulated by cytokines. In addition, the protective effect of the non-selective KDAC inhibitor ITF2357 and interdependent regulation of four selected KDACs were investigated. METHODS: The beta cell line INS-1 and intact rat and human islets were exposed to cytokines with or without ITF2357. Expression of mRNA was assessed by real-time PCR and selected targets validated at the protein level by immunoblotting. Effects on cytokine-induced toxicity were investigated by in vitro assays. RESULTS:Hdac1 to Hdac11 were expressed and differentially regulated by cytokines in INS-1 cells and rat islets. HDAC1, -2, -6 and -11 were found to be expressed and regulated by cytokines in human islets. ITF2357 protected against cytokine-induced beta cell apoptosis and counteracted cytokine-induced attenuation of basal insulin secretion. In addition, cytokine-induced regulation of Hdac2 and Hdac6, but not Hdac1 and Hdac11, was reduced by KDAC inhibition. CONCLUSIONS/ INTERPRETATION: All classical KDAC genes are expressed by beta cells and differentially regulated by cytokines. Based on the relative expression levels and degree of regulation by cytokines, we propose that HDAC1, -2, -6 and -11 are of particular importance for beta cell function. These observations may help in the design of specific KDAC inhibitors to prevent beta cell destruction in situ and in islet grafts.
Authors: Lucjan S Wyrwicz; Paweł Gaj; Marcin Hoffmann; Leszek Rychlewski; Jerzy Ostrowski Journal: Acta Biochim Pol Date: 2007-03-09 Impact factor: 2.149
Authors: Flavio Leoni; Gianluca Fossati; Eli C Lewis; Jae-Kwon Lee; Giulia Porro; Paolo Pagani; Daniela Modena; Maria Lusia Moras; Pietro Pozzi; Leonid L Reznikov; Britta Siegmund; Giamila Fantuzzi; Charles A Dinarello; Paolo Mascagni Journal: Mol Med Date: 2005 Jan-Dec Impact factor: 6.354
Authors: Franck Dequiedt; Johan Van Lint; Emily Lecomte; Viktor Van Duppen; Thomas Seufferlein; Jackie R Vandenheede; Ruddy Wattiez; Richard Kettmann Journal: J Exp Med Date: 2005-02-28 Impact factor: 14.307
Authors: Dan P Christensen; Mattias Dahllöf; Morten Lundh; Daniel N Rasmussen; Mette D Nielsen; Nils Billestrup; Lars G Grunnet; Thomas Mandrup-Poulsen Journal: Mol Med Date: 2011-01-25 Impact factor: 6.354
Authors: M Lundh; D P Christensen; M Damgaard Nielsen; S J Richardson; M S Dahllöf; T Skovgaard; J Berthelsen; C A Dinarello; A Stevenazzi; P Mascagni; L G Grunnet; N G Morgan; T Mandrup-Poulsen Journal: Diabetologia Date: 2012-07-07 Impact factor: 10.122
Authors: Mattias S Dahllöf; Dan P Christensen; Mette Harving; Bridget K Wagner; Thomas Mandrup-Poulsen; Morten Lundh Journal: J Interferon Cytokine Res Date: 2014-07-25 Impact factor: 2.607
Authors: Dan Ploug Christensen; Conny Gysemans; Morten Lundh; Mattias Salling Dahllöf; Daniel Noesgaard; Søren Fisker Schmidt; Susanne Mandrup; Nikolai Birkbak; Christopher T Workman; Lorenzo Piemonti; Lykke Blaabjerg; Valmen Monzani; Gianluca Fossati; Paolo Mascagni; Steven Paraskevas; Reid A Aikin; Nils Billestrup; Lars Groth Grunnet; Charles A Dinarello; Chantal Mathieu; Thomas Mandrup-Poulsen Journal: Proc Natl Acad Sci U S A Date: 2014-01-06 Impact factor: 11.205
Authors: Suzhao Li; Gianluca Fossati; Carlo Marchetti; Daniela Modena; Pietro Pozzi; Leonid L Reznikov; Maria Luisa Moras; Tania Azam; Antonio Abbate; Paolo Mascagni; Charles A Dinarello Journal: J Biol Chem Date: 2014-12-01 Impact factor: 5.157
Authors: Mattias S Dahllöf; Dan P Christensen; Morten Lundh; Charles A Dinarello; Paolo Mascagni; Lars G Grunnet; Thomas Mandrup-Poulsen Journal: Islets Date: 2012 Nov-Dec Impact factor: 2.694